Uveal melanoma is the commonest primary malignancy in the eye. Despite successful eradication of the primary tumour, about 50% of all patients ultimately develop metastatic disease,' which is invariably fatal.2 Factors reported to be associated with an increased risk of metastatic disease include tumour size,3 number of epithelioid cells per high power field,4 nucleolar size,5 hyperploidy,6 lymphocytic infiltration,7 tumour pigmentation,8-'0 presence of closed microvascular loops,"1 acoustic tissue characteristics,12 extrascleral tumour extension,8 10 13 ciliary body involvement,14 old age at diagnosis,9 rapid tumour regression after radiotherapy, '5 16 and others.
In specialist centres, enucleation is avoided whenever possible in favour of less mutilating forms of treatment, which are aimed at conserving vision and the eye and which include brachytherapy, 17-19 teletherapy,20 21 and trans-scleral local resection. [22] [23] [24] [25] Previous studies suggest that survival after enucleation is not significantly better than after radiotherapy26 or local resection. 27 Sight conserving treatment has been encouraged by a widely shared belief that treatment does not influence survival in patients with medium sized and large tumours because fatal tumour dissemination has already occurred by the time the patient first presents.28 29 The aims of this study were to (i) identify predictive risk factors for metastasis after transscleral local resection, and (ii) establish whether the prognosis for survival is affected by incomplete tumour resection and by adjunctive plaque radiotherapy.
Patients, materials, and methods PREOPERATIVE ASSESSMENT Our methods of preoperative assessment are described elsewhere.25 30 The following data were obtained at the time of treatment or subsequently by reviewing photographs and records: (i) patient age and sex; (ii) Snellen visual acuity measured with spectacles, pinhole, or unaided, as clinically indicated; (iii) tumour height and largest and smallest basal tumour diameters as measured by B-scan ultrasonography; (iv) location of anterior and posterior margins of the tumour; and (v) coronal and sagittal location of the tumour. The tumour was said to have 'posterior tumour extension' if its posterior margin was situated at or within 1 disc diameter of the disc margin or fovea. The coronal location of the tumour was categorised as 'vertical' if the 'centre of gravity' of the tumour was located on a vertical line passing through the fovea, and 'nasal' or 'temporal' if the tumour was placed medical or lateral to the fovea.
SURGICAL TECHNIQUE
The surgical techniques are described in detail elsewhere.25 Briefly, a rectangular lamellar scleral flap, was dissected over the tumour, after defining the tumour margins by transpupillary transillumination. The deep sclera and choroid were divided some 3-5 mm from the tumour, which was removed avoiding retinal damage whenever possible. Since 1986, partial ocular decompression was routinely performed, either before the dissection of the scleral flap by three port vitrectomy (WSF), or after preparation of the flap via a single sclerotomy and without infusion (BED).
Haemorrhage was minimised by lowering the systolic blood pressure to approximately 40- PATIENT FOLLOW UP After the local resection, patients were reviewed after 1 month, 6 months, and then annually, if possible, unless more frequent visits were indicated because of complications. The following data were recorded: (i) visual acuity, measured with a Snellen chart either unaided, or with current spectacles, or pinhole as appropriate; and (ii) ocular and systemic complications together with the date of their diagnosis. Persistent intraocular tumour after local resection was categorised as (i) 'residual tumour' if present from the time of the operation (that is, diagnosed within the first 40 postoperative days), or (ii) 'recurrent tumour' if the tumour regrew from invisible microscopic deposits after apparently complete resection. Residual tumour and recurrent tumour were categorised as 'possible' when pigmentation could not be differentiated from retinal pigment epithelial hyperplasia and 'definite' when the diagnosis was certain. During most of the study, postoperative laser photocoagulation was applied only to 'possible' or 'definite' residual and recurrent tumours, whereas in the latter part of the study a double row of confluent photocoagulation burns was routinely applied to margins of the coloboma in all patients irrespective of whether or not residual tumour was suspected. Information about the cause of death was obtained from family practitioners, referring ophthalmologists, and cancer registries. If a post mortem was not performed, the cause of death was assumed to be metastatic melanoma unless an alternative diagnosis had been confirmed. Follow up for patients still alive at the close of the study varied from 7 days to 20-9 years, with a median of 33 months. Ninety six patients were followed up for more than 5 years and 24 of these were followed up for more than 10 years.
In relation to metastatic death, p values for the univariate comparisons of time to death between different groups were derived by fitting Cox's proportional hazards model32 to the data. Estimates of relative event rates were obtained in the same way. A forward stepwise procedure (p to enter=p to remove=0-05) was used in conjunction with Cox's proportional hazards model to identify those factors influencing metastatic death most profoundly. A backward stepwise procedure was also used and gave the same model as the forward procedure and is therefore not referred to specifically in the results section. As with the outcome of any statistical analysis, the findings presented should be interpreted critically taking into account both the statistical and the clinical levels of significance. Such caution is all the more necessary with stepwise procedures as they produce exaggerated p values. In the analysis of the effect of various postoperative events on the risk of metastatic death, Cox's proportional hazards model was again used together with techniques for modelling the effect of time dependent covariates.32 Such techniques allow the influence of postoperative events to be estimated properly by including them only after the time that they occur for each patient. In these models the pretreatment and treatment variables already shown to be of prognostic importance were also included. Kaplan-Meier estimates33 were used to draw survival curves. These curves were terminated when there were fewer than five patients at risk.
Patients were included in the study if they had primary choroidectomy, cyclochoroidectomy (with or without iridectomy) or iridocyclectomy. They were excluded from the study if the operation was abandoned in favour of another form of conservative therapy or enucleation.
For the statistical analysis, persistent tumour in enucleated eyes was categorised as showing extraocular extension only if the extraocular extension was diagnosed at the same time as the recurrent tumour. (Table 1 ). The metastatic disease and another eight patients tumours had a mean largest tumour died of other causes, which included carcidiameter (LTD) of 13 1 (SD 4 1) mm and a noma of the bronchus (two), pneumonia mean thickness of 7'5 (SD 3 0) mm, as (two), myocardial infarction (two), suicide measured by the pathologist. The tumours (one), and gastroenteritis (one). extended anterior to the ora serrata in 166 cases and to within 1 disc diameter (DD) of the optic disc margin or fovea in 42 cases. PREDICTIVE FACTORS Epithelioid cells were noted in 135 tumours. A Univariate analysis showed that the variables total of 50 patients received adjunctive plaque predicting metastatic death were (i) age radiotherapy at the time of the local resection. greater than 60 years at the time of diagnosis As reported more fully in a parallel study, (p<0 001), (ii) presence of epithelioid cells residual tumour diagnosed immediately after (p<O OO1), (iii) largest tumour diameter of 16 the local resection occurred in 24 eyes and mm or more (p<0 001), (iv) choroidectomy delayed tumour recurrence from microscopic and cyclochoroidectomy types of local resecdeposits occurred in another 56 eyes.34 Thirty tion (p=0033) ( Table 1) . A forward stepwise three eyes were enucleated because of residual Cox regression indicated in a multivariate settumour, which was categorised as 'large' ting that the statistically significant predictors All two way interactions between variables in the above multivariate model were examined and this suggested that an interaction existed between sagittal location and tumour cell type, with mixed/epithelioid cell tumours being associated with a higher rate of metastatic death if located superiorly in the eye (p=0O053). Although this interaction did not reach the conventional level of statistical significance (p<0 05), it was included as an extra term in the final statistical model (Table  3) because it accounted for the strong significance of sagittal tumour location in the multivariate model compared with nonsignificance in the univariate setting. In the final multivariate model, the predictive factors were therefore (i) patient age greater than 60 years at diagnosis (p<0Q001), (ii) largest tumour diameter of 16 mm or more (p=0Q001), (iii) mixed/epithelioid cell type (p=0.002), (iv) superior tumour of mixed/ epithelioid cell type (over and above (iii)) (p=0 002), and (v) lack of adjunctive plaque radiotherapy (p=0021) ( Table 3) . The predictive factors were each given a score of +1 and patients were allocated into risk groups according to the sum ofthese risk factors. Figure 5 Table 5 ).
Discussion This is the largest study on survival after local resection performed to date, because it includes 332 patients, with maximum follow up of up to almost 21 years, few losses to follow up, and documentation of a large number of variables. Many of the adverse prognostic factors after local resection have previously been shown to be important in patients treated by enucleation or radiotherapy. These include presence of epithelioid cells, large tumour size and old age at time of treatment. Similarly, the lack of significance of sex has previously been noted after other forms of treatment. 35 There are a few notable differences between our results and those of other workers. Unlike other studies,9 our data do not show a statistically increased risk of metastatic disease in patients with anterior tumour extension, although there does seem to be a trend in this direction. This is perhaps because few of the tumours we resected were located entirely behind the equator of the eye. Our finding that mixed and epithelioid cell tumours are particularly associated with a poorer prognosis if located superiorly has not been reported previously. Whether other workers have not studied sagittal tumour location or whether they have found this variable to be insignificant is uncertain. This surprising statistical result may be due to chance or to previously unrecognised factors. In any case, the combined effect of sagittal tumour location and tumour cell type on survival merits further study.
An important finding is that the risk of metastatic death is higher in patients who undergo secondary enucleation for persistent tumour that is large or that extends extraocularly. The numbers of patients with these adverse features are small so that these results are only tentative and need to be confirmed by further studies; however, data published by other workers indicate that failure of local tumour control is associated with a significantly increased risk of metastatic death after plaque radiotherapy36 37 In this study, (i) histologically incomplete tumour resection, and (ii) small persistent tumours treated by enucleation were not associated with an increased risk of metastatic disease. This is possibly because prompt and successful secondary treatment prevented growth and dedifferentiation of residual tumour cells in the eye, or because many of the persistent tumours had a low metastatic potential, or both of these reasons. Treatment of known residual or recurrent disease may also have inadvertently prevented metastatic spread. from unrecognised microscopic tumour deposits, as implied by the efficacy of adjunctive plaque radiotherapy (see below). Some patients with apparently complete excision on histology and ophthalmoscopy developed local tumour recurrence and this suggests that microscopic tumour seedlings and extensions were sometimes missed both by the pathologist and the surgeon.
Adjunctive plaque radiotherapy was introduced in 1986 as a routine procedure to reduce the incidence of local tumour recurrence, and indeed in a parallel study, we show that adjunctive plaque radiotherapy is effective at preventing local tumour recurrence after trans-scleral local resection (Cox multivariate analysis, p=O0018). 34 In 1989, we adopted more aggressive resection with wider clearance margins, and adjunctive laser photocoagulation to reduce the incidence of radiational complications. The finding that adjunctive plaque radiotherapy is associated with a better prognosis for survival is serendipitous. Our results suggest that in eradicating microscopic tumour deposits left in the eye after local resection, adjunctive plaque radiotherapy prevents not only local tumour recurrence but also metastasis. The effect of adjunctive plaque radiotherapy on metastasis was not studied in a randomised and prospective fashion so that further investigation is necessary. Nevertheless, it is noteworthy that patients treated with adjunctive plaque radiotherapy tended to have larger tumours and would therefore have been expected to have a higher incidence of metastatic disease not lower. Lack of adjunctive plaque radiotherapy seemed to be associated with an increased mortality even in patients without residual or recurrent disease (28/206 14% versus 2/44 5%). This crude estimate is in keeping with the results of our multivariate analyses, which show adjunctive plaque radiotherapy to be an independent prognostic indicator even when enucleation for persistent tumour is included in the model (p=0-031) ( Table 5) . These results would seem to suggest that adjunctive plaque radiotherapy may prevent metastatic disease in some cases because it prevents seeding from microscopic deposits. We, therefore, share the concerns expressed by Robertson and associates about residual tumour after local resection, although we find that deposits in uveal tissue are more troublesome than deposits in sclera or retina.39 On the basis of these findings, we now excise tumours with wider clearance margins than before and routinely perform adjunctive treatment, which consists either of (i) ruthenium plaque radiotherapy or, if this is not technically possible, (ii) laser photocoagulation and cryotherapy to the margins and bed of the coloboma.
The 5 year mortality rates for patients with largest basal tumour diameters of <11 mm, 11-15 mm, and > 15 mm were approximately 3%, 20%, and 44°/O (Fig 3) . These results seem better than those reported in a meta-analysis: by Diener-West and associates, which shows the 5 year mortality rates after treatment of uveal melanoma to be 16% for small tumours (large tumour diameter < 10-11 mm and tumour thickness <2 mm-3 mm), 32% for medium tumours (large tumour diameter < 15 mm-1 6 mm and tumour thickness 3-8 mm), and 53% for large tumours ( from different studies. Because we reserve local resection for patients we consider to be unsuitable for radiotherapy, there would not seem to be much scope for performing comparisons between these two treatments in a randomised prospective fashion.
The results of the present study with regard to the influence of adjunctive plaque radiotherapy on survival are only tentative as they were not obtained in a randomised prospective fashion. If survival is indeed improved by adjunctive treatment, this would imply that (i) residual tumour can cause metastatic disease, (ii) fatal tumour dissemination can occur after the patient presents, even if the tumour is of medium size or large, and that (iii) all patients without evidence of metastasis should receive urgent and total tumour destruction.
In the present study, differences in survival rates according to adjunctive radiotherapy seem to appear as early as the fourth year after treatment (Fig 4) . This tentative result is not in keeping with the views expressed by others that (i) metastatic death within the first 7 years postoperatively is always due to tumour dissemination before treatment and that (ii) a minimum follow up interval of 7 years is essential to allow any comparisons between different forms of treatment.43 In this respect, it is noteworthy that (i) factors predicting metastatic death within the first 2 years may be different from those that predict more delayed onset of metastatic disease and death,'6 and that (ii) the prognostic values of pretreatment variables may decline with time. 44 In conclusion, this study confirms the findings of other workers that epithelioid cell type, largest basal tumour diameter, and old age are useful predictors of metastatic death and, in addition, identifies other adverse prognostic factors, such as lack of adjunctive plaque radiotherapy, delayed or inadequate treatment of residual or recurrent tumour, and superior tumour location within the eye of mixed and epithelioid tumours. These tentative results appear to contradict some general beliefs about the natural history of uveal melanomas and imply that these tumours should be treated aggressively and urgently. The prognostic score developed in this study allows survival after local resection to be described in a more meaningful manner than has hitherto been possible and in future may facilitate the selection of patients for adjunctive systemic immunotherapy or chemotherapy. The authors wish to thank all the ophthalmologists who have referred patients to the Ophthalmic Oncology Service and who have returned questionnaires. We also acknowledge the contribution of Professor W R Lee, who performed the pathological examination of the resected tumours. 
